• image 01
    Volume 1, No.1, 2012
  • image 02
    Volume 1, No.2, 2012
  • image 01
    Volume 1, No.3, 2012
  • image 02
    Volume 2, No.1, 2013
  • image 02
    Volume 2, No.2, 2013
  • image 02
    Volume 2, No.S1, 2013
  • image 02
    Volume 2, No.3, 2013
  • image 02
    Volume 2, No.4, 2013
  • image 02
    Volume 3, No.1, 2014
  • image 02
    Volume 3, No.2, 2014
  • Volume 3, No3
    Volume 3, No.3, 2014
  • Volume 3, No4
    Volume 3, No.4, 2014
  • Volume 4, No1
    Volume 4, No.1, 2015
  • Volume 4, No2
    Volume 4, No.2, 2015
  • Volume 4, No3
    Volume 4, No.3, 2015
  • Volume 4, No4
    Volume 4, No.4, 2015
  • Volume 5, No1
    Volume 5, No.1, 2016
  • Login|Register
  • Total citations for the following article is (4) : Details of Citation

    Design and One-Pot Synthesis of (1H, 3H) Imidazo [4,5-b] Pyridines: Novel Therapeutic Agents Against M. tuberculosis
    SUNIL L. HARER and MANISH S. BHATIA
    Bharati Vidyapeeth’s College of Pharmacy, Near Chitranagari, Kolhapur-416013, (M.S), IndiaBharati Vidyapeeth’s College of Pharmacy, Near Chitranagari, Kolhapur-416013, (M.S), India
    Chem Sci Trans., 2015   |   DOI:10.7598/cst2015.936    |    View Abstract | FullText    |   

    This article has been cited by :

    Vajinder Kumar. Sanjay Patel and Rahul Jain; New structural classes of antituberculosis agents   
    Medicinal Research Reviews; Volume 38, Issue2 March 2018 Pages 684-740    | View at Journal site     | ISI   
    Sourav De, Ashok Kumar S K et al., Pyridine: the scaffolds with significant clinical diversity   
    Royal Society of Chemistry, 2022, 12, 15385-15406    | View at Journal site     | ISI   
    Suraj N. Mali & Anima Pandey, Recent Developments in Medicinal and In Silico Applications of Imidazopyridine Derivatives: Special Emphasis on Malaria, Trypanosomiasis, and Tuberculosis    
    Chemistry Africa, 2022, volume 5, pages 1215–1236     | View at Journal site     | ISI   
    SELMA BOURICHI, HOURIA MISBAHI, YOUSSEF KANDRI RODI et al., In Vitro Evaluation of the Multidrug Resistance Reversing Activity of Novel Imidazo[4,5-b]pyridine Derivatives   
    Anticancer Research, 2018, 38(7), 3999-4003    | View at Journal site     | ISI